Concord Days Sales Outstanding vs Capex To Operating Cash Flow Analysis

CCM Stock

USD 5.00 0.56 12.61%

Concord Medical financial indicator trend analysis is way more than just evaluating Concord Medical Services prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Concord Medical Services is a good investment. Please check the relationship between Concord Medical Days Sales Outstanding and its Capex To Operating Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Days Sales Outstanding vs Capex To Operating Cash Flow

Days Sales Outstanding vs Capex To Operating Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Concord Medical Services Days Sales Outstanding account and Capex To Operating Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Concord Medical's Days Sales Outstanding and Capex To Operating Cash Flow is -0.12. Overlapping area represents the amount of variation of Days Sales Outstanding that can explain the historical movement of Capex To Operating Cash Flow in the same time period over historical financial statements of Concord Medical Services, assuming nothing else is changed. The correlation between historical values of Concord Medical's Days Sales Outstanding and Capex To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Sales Outstanding of Concord Medical Services are associated (or correlated) with its Capex To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Operating Cash Flow has no effect on the direction of Days Sales Outstanding i.e., Concord Medical's Days Sales Outstanding and Capex To Operating Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.12

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Days Sales Outstanding

Capex To Operating Cash Flow

Most indicators from Concord Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Concord Medical Services current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

As of the 26th of November 2024, Enterprise Value is likely to grow to about 6.9 B, while Selling General Administrative is likely to drop about 190.2 M.

Concord Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Cash	Other Assets	Long Term Debt	Good Will	Common Stock Shares Outstanding	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity
Total Assets		0.66	0.51	-0.57	0.75	0.04	0.07	0.78	0.64	-0.72	0.33	0.83	0.71	0.72	0.75	0.8	0.76	0.73	0.79	-0.73	0.54	0.93	-0.15	-0.33	-0.18	0.73
Other Current Liab	0.66		0.82	-0.65	0.7	-0.05	-0.06	0.69	0.66	-0.81	0.5	0.85	0.52	0.48	0.76	0.81	0.71	0.37	0.79	-0.74	0.49	0.62	-0.21	-0.24	-0.42	0.57
Total Current Liabilities	0.51	0.82		-0.42	0.49	-0.12	-0.09	0.45	0.54	-0.66	0.64	0.76	0.17	0.55	0.56	0.69	0.56	0.15	0.7	-0.54	0.59	0.38	-0.11	-0.36	-0.17	0.65
Total Stockholder Equity	-0.57	-0.65	-0.42		-0.86	0.45	0.13	-0.92	-0.74	0.82	-0.4	-0.82	-0.49	-0.04	-0.94	-0.86	-0.86	-0.73	-0.86	0.95	-0.47	-0.76	0.58	0.44	0.8	-0.14
Other Liab	0.75	0.7	0.49	-0.86		-0.27	0.21	0.86	0.66	-0.73	0.35	0.87	0.7	0.37	0.9	0.82	0.82	0.6	0.82	-0.87	0.37	0.82	-0.42	-0.43	-0.52	0.43
Cash	0.04	-0.05	-0.12	0.45	-0.27		0.17	-0.28	-0.43	0.33	-0.41	-0.21	0.08	0.3	-0.34	-0.26	-0.35	-0.16	-0.35	0.38	-0.39	-0.21	0.32	0.85	0.62	0.22
Other Assets	0.07	-0.06	-0.09	0.13	0.21	0.17		-0.11	-0.46	0.29	-0.24	0.03	0.47	0.19	-0.13	-0.17	-0.29	-0.19	-0.17	0.21	-0.55	-0.03	-0.14	0.08	0.41	0.12
Long Term Debt	0.78	0.69	0.45	-0.92	0.86	-0.28	-0.11		0.76	-0.85	0.39	0.9	0.62	0.32	0.98	0.95	0.92	0.83	0.94	-0.96	0.52	0.88	-0.4	-0.44	-0.65	0.38
Good Will	0.64	0.66	0.54	-0.74	0.66	-0.43	-0.46	0.76		-0.89	0.5	0.72	0.33	0.32	0.82	0.79	0.9	0.65	0.81	-0.87	0.84	0.74	-0.33	-0.59	-0.7	0.41
Common Stock Shares Outstanding	-0.72	-0.81	-0.66	0.82	-0.73	0.33	0.29	-0.85	-0.89		-0.64	-0.87	-0.5	-0.39	-0.88	-0.9	-0.86	-0.68	-0.91	0.92	-0.73	-0.76	0.45	0.52	0.64	-0.47
Other Current Assets	0.33	0.5	0.64	-0.4	0.35	-0.41	-0.24	0.39	0.5	-0.64		0.57	0.07	0.34	0.44	0.53	0.43	0.29	0.57	-0.5	0.49	0.29	-0.41	-0.6	-0.23	0.41
Total Liab	0.83	0.85	0.76	-0.82	0.87	-0.21	0.03	0.9	0.72	-0.87	0.57		0.61	0.53	0.93	0.97	0.87	0.65	0.96	-0.9	0.58	0.82	-0.37	-0.47	-0.44	0.61
Intangible Assets	0.71	0.52	0.17	-0.49	0.7	0.08	0.47	0.62	0.33	-0.5	0.07	0.61		0.35	0.55	0.51	0.42	0.56	0.49	-0.51	0.16	0.69	-0.32	-0.09	-0.15	0.31
Common Stock	0.72	0.48	0.55	-0.04	0.37	0.3	0.19	0.32	0.32	-0.39	0.34	0.53	0.35		0.35	0.45	0.4	0.19	0.45	-0.29	0.25	0.46	0.18	-0.24	0.27	0.99
Property Plant Equipment	0.75	0.76	0.56	-0.94	0.9	-0.34	-0.13	0.98	0.82	-0.88	0.44	0.93	0.55	0.35		0.96	0.96	0.74	0.96	-0.98	0.55	0.86	-0.41	-0.5	-0.69	0.43
Short Long Term Debt Total	0.8	0.81	0.69	-0.86	0.82	-0.26	-0.17	0.95	0.79	-0.9	0.53	0.97	0.51	0.45	0.96		0.94	0.71	0.99	-0.94	0.63	0.83	-0.31	-0.48	-0.56	0.53
Property Plant And Equipment Net	0.76	0.71	0.56	-0.86	0.82	-0.35	-0.29	0.92	0.9	-0.86	0.43	0.87	0.42	0.4	0.96	0.94		0.72	0.94	-0.95	0.68	0.85	-0.29	-0.56	-0.66	0.49
Current Deferred Revenue	0.73	0.37	0.15	-0.73	0.6	-0.16	-0.19	0.83	0.65	-0.68	0.29	0.65	0.56	0.19	0.74	0.71	0.72		0.7	-0.78	0.52	0.83	-0.53	-0.28	-0.47	0.22
Net Debt	0.79	0.79	0.7	-0.86	0.82	-0.35	-0.17	0.94	0.81	-0.91	0.57	0.96	0.49	0.45	0.96	0.99	0.94	0.7		-0.94	0.66	0.83	-0.31	-0.58	-0.58	0.53
Retained Earnings	-0.73	-0.74	-0.54	0.95	-0.87	0.38	0.21	-0.96	-0.87	0.92	-0.5	-0.9	-0.51	-0.29	-0.98	-0.94	-0.95	-0.78	-0.94		-0.61	-0.85	0.49	0.51	0.74	-0.38
Accounts Payable	0.54	0.49	0.59	-0.47	0.37	-0.39	-0.55	0.52	0.84	-0.73	0.49	0.58	0.16	0.25	0.55	0.63	0.68	0.52	0.66	-0.61		0.56	-0.13	-0.52	-0.4	0.32
Non Current Assets Total	0.93	0.62	0.38	-0.76	0.82	-0.21	-0.03	0.88	0.74	-0.76	0.29	0.82	0.69	0.46	0.86	0.83	0.85	0.83	0.83	-0.85	0.56		-0.26	-0.43	-0.46	0.49
Non Currrent Assets Other	-0.15	-0.21	-0.11	0.58	-0.42	0.32	-0.14	-0.4	-0.33	0.45	-0.41	-0.37	-0.32	0.18	-0.41	-0.31	-0.29	-0.53	-0.31	0.49	-0.13	-0.26		0.22	0.4	0.11
Cash And Short Term Investments	-0.33	-0.24	-0.36	0.44	-0.43	0.85	0.08	-0.44	-0.59	0.52	-0.6	-0.47	-0.09	-0.24	-0.5	-0.48	-0.56	-0.28	-0.58	0.51	-0.52	-0.43	0.22		0.45	-0.3
Net Receivables	-0.18	-0.42	-0.17	0.8	-0.52	0.62	0.41	-0.65	-0.7	0.64	-0.23	-0.44	-0.15	0.27	-0.69	-0.56	-0.66	-0.47	-0.58	0.74	-0.4	-0.46	0.4	0.45		0.16
Common Stock Total Equity	0.73	0.57	0.65	-0.14	0.43	0.22	0.12	0.38	0.41	-0.47	0.41	0.61	0.31	0.99	0.43	0.53	0.49	0.22	0.53	-0.38	0.32	0.49	0.11	-0.3	0.16

Click cells to compare fundamentals

Concord Medical Account Relationship Matchups

Concord Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.3B	5.3B	6.2B	6.0B	6.1B	4.0B
Other Current Liab	274.7M	243.2M	646.0M	397.2M	716.3M	752.2M
Total Current Liabilities	627.5M	512.1M	804.5M	1.1B	2.0B	2.0B
Total Stockholder Equity	(122.8M)	(663.0M)	(1.4B)	(1.9B)	(2.1B)	(2.0B)
Other Liab	287.0M	270.2M	230.1M	268.9M	309.2M	324.7M
Cash	74.3M	334.3M	157.4M	158.3M	58.1M	55.2M
Other Assets	661.1M	409.9M	250.6M	24.0M	27.6M	26.2M
Long Term Debt	1.3B	2.0B	2.2B	2.5B	2.0B	2.1B
Good Will	210.4M	213.7M	581.9M	575.4M	661.7M	694.8M
Common Stock Shares Outstanding	43.4M	43.4M	43.7M	4.4M	3.9M	3.7M
Other Current Assets	4.3M	31.4M	258.4M	386.4M	445.2M	467.5M
Total Liab	2.4B	2.9B	3.5B	4.0B	4.3B	4.5B
Intangible Assets	532.5M	522.8M	1.1B	762.1M	323.3M	435.8M
Property Plant Equipment	2.5B	3.2B	3.8B	3.9B	4.4B	4.7B
Short Long Term Debt Total	1.9B	2.4B	2.7B	3.2B	3.3B	3.5B
Property Plant And Equipment Net	2.5B	3.2B	3.3B	3.4B	4.1B	4.3B
Current Deferred Revenue	3.2M	87.7M	81.0M	100.8M	59.4M	32.4M
Net Debt	1.8B	2.0B	2.6B	3.1B	3.2B	3.4B
Retained Earnings	(1.8B)	(2.5B)	(3.3B)	(3.8B)	(4.1B)	(3.9B)
Accounts Payable	8.3M	18.6M	102.5M	146.7M	129.2M	135.7M
Non Current Assets Total	4.0B	4.7B	5.6B	5.2B	5.4B	3.3B
Non Currrent Assets Other	661.1M	107.5M	13.6M	23.2M	11.0M	10.4M
Cash And Short Term Investments	74.3M	334.3M	157.4M	158.3M	58.1M	55.2M
Net Receivables	199.6M	280.4M	130.6M	130.3M	73.5M	69.8M
Liabilities And Stockholders Equity	4.3B	5.3B	6.2B	6.0B	6.1B	4.3B
Non Current Liabilities Total	1.8B	2.4B	2.7B	2.9B	2.4B	1.3B
Other Stockholder Equity	1.8B	1.8B	1.9B	1.9B	2.0B	1.7B
Property Plant And Equipment Gross	2.5B	3.4B	3.6B	3.8B	4.1B	4.3B
Total Current Assets	282.5M	676.0M	584.5M	759.8M	617.2M	736.9M
Accumulated Other Comprehensive Income	(97.3M)	(46.4M)	(29.5M)	(27.8M)	(65.4M)	(62.1M)
Short Term Debt	341.3M	162.5M	35.1M	548.5M	1.1B	1.1B
Short Term Investments	50M	35.2M	25.0M	2.7M	2.4M	2.3M
Inventory	4.3M	21.6M	38.1M	84.8M	40.3M	28.3M
Net Tangible Assets	(865.7M)	(1.4B)	(2.6B)	(2.8B)	(2.5B)	(2.4B)
Long Term Investments	64.9M	313.0M	390.6M	437.9M	394.7M	319.4M
Short Long Term Debt	328.4M	148.9M	299.4M	512.6M	1.0B	537.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:

How To Invest In Concord

Details

Is Concord Stock a good investment?

Details

What is Concord Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(11.98)

Revenue Per Share

107.978

Quarterly Revenue Growth

(0.23)

Return On Assets

(0.04)

Return On Equity

(0.32)

The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Concord Days Sales Outstanding vs Capex To Operating Cash Flow Analysis

Days Sales Outstanding vs Capex To Operating Cash Flow

Days Sales Outstanding vs Capex To Operating Cash Flow Correlation Analysis

Correlation Coefficient

Days Sales Outstanding

Capex To Operating Cash Flow

Concord Medical fundamental ratios Correlations

Concord Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Concord Medical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 0.99	Common Stock
Net Debt	+ 0.99	Short Long Term Debt Total
Property Plant Equipment	+ 0.98	Long Term Debt
Short Long Term Debt Total	+ 0.97	Total Liab
Net Debt	+ 0.96	Total Liab
Short Long Term Debt Total	+ 0.96	Property Plant Equipment

Retained Earnings	- 0.98	Property Plant Equipment
Retained Earnings	- 0.96	Long Term Debt
Retained Earnings	- 0.95	Property Plant And Equipment Net
Retained Earnings	- 0.94	Net Debt
Retained Earnings	- 0.94	Short Long Term Debt Total
Property Plant Equipment	- 0.94	Total Stockholder Equity